Chapter 4: Pharmacokinetics, Pharmacodynamics Drug Interactions Flashcards
pharmakinetics
Pharmacokinetics is the study of drug movement throughout the body
Pharmacokinetics also includes drug metabolism (biotransformation) and drug excretion
Passage of drugs across membranes
Action of body on the drug *
Pharmacodynamics
The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects are produced
The study of what drugs do to the body and how they do it
action of drug on the body*
pharmacokinetics: absorption
movement of drug from site of administration into the blood
pharmacokinetics: distributions
movement of the drug form the blood to the interstitial spaces, tissues and body cells (site of action)
pharmacokinetics: metabolism
biotransformation, enzymatic mediated alternation of the drug structures
most often takes place in the liver
hepatic micrsomal enzyme system 450 sysem
pharmacokinetics: excretion
movement of drugs and their metabolites out of the body
both metabolism and excretion together
Defined as the removal of drugs from the body
Drugs and their metabolites can exit the body through urine, sweat, saliva, breast milk, or expired air
passage of drugs across membranes
channels and pores -only smallest of componds (K, Na) can pass thru channels and pores
transport systems (p-glycoprotein) -selective, depeonds on structure of drug
direct penetration of the membranes (mot common, like dissolves like -cell membranes are primarily lipids, to penetrate drugs must be lipid solable)
For most drugs, movement throughout the body is dependent on the drug’s ability to penetrate membranes directly
Most drugs are too large to pass through channels or pores
Most drugs lack transport systems to help them cross all of the membranes that separate them from their sites of action, metabolism, and excretion
p-glycoprotein
P-glycoprotein: Transmembrane protein that transports a wide variety of drugs out of cells
Liver: Transports drugs into the bile for elimination
Kidney: Pumps drugs into the urine for excretion
Placenta: Transports drugs back into the maternal blood
Brain: Pumps drugs into the blood to limit drugs’ access to the brain
Polar molecules
No net charge, uneven distribution of a charge (pos and neg charges within the molcule tend to congregate separate. Ex. Water.
Polar dissolves in polar solvents
Ions
moleculs that have a net electrical charge
can only cross membrane if very small compound, most mst be nonionizd to cross membrane
most drugs are either weak organic acids or weak organic bases, which can exist in charged and uncharged form -electrical charge depends on the pH of surrounding medium.
Quaternary ammonium compounds
Molecules that contain at least one atom of nitrogen and carry a positive charge at all times
pH-dependent ionization
Acid is a proton donor: Tends to ionize in basic (alkaline) media. acid is best absorbed in acdic environment ex gastric acid.
Base is a proton acceptor: Tends to ionize in acidic media
Ion trapping (pH partitioning)
drgs tend to go to the side that favors their ionization
Acidic drugs accumulate on the alkaline side
Basic drugs accumulate on the acidic side
absorption
Movement of a drug from its site of administration into the blood
The rate of absorption determines how soon effects will begin
The amount of absorption helps determine how intense the effects will be
factors affecting drug absorption
Rate of dissolution
Surface area
Lager = more absorption
Blood flow
More flow = more absorption
Lipid solubility
Lipid solvable absorbed quickly bc they can cross lipid cell membrane
pH partitioning
Greater absorption with differences bc the pH of plasma and pH at site of administration such that the drug has greater tendency to be ionized in the plasma
IV admin
Barriers to absorption: none
Absorption pattern: instant
Advantages: rapid onset, reach peak levels
Disadvantages: irreversible, must be water soluble
IM admin
Barriers to absorption: cap walls are easy to pass, blood flow to tissue is important
Absorption pattern: rapid with water soluble, slow with poorly soluble drugs
Advantages: good way to admin poorly soluble drug, allows for depot prep
Disadvantages: discomfort and potential for injury
SQ admin
No significant barriers to absorption
Similar to IM
oral admin
Barriers to absorption: the epithelial lining of the GI tract so y need to have adequate cellar structure there to facilitate absorption
Absorption pattern: slower and chance for variability
Drug movement after absorption: allow absorption to take place, also first pass effect (oral meds have to go to liver for biotransformation)
Advantages: easy admin, potentially reversible
Disadvantages: inactivation from gastric acid and digestive enzymes, availability of the drug depends on the first pass in the liver
pharm preps for oral admin
Tablets
Take time to dissolve
Enteric-coated preparations
Coating over tablet that takes time to dissolve
Pass thru gastric and absorbed in small int
Sustained-release preparations
Developed so med is all dissolved and absorbed at the same time
Bits of release as time passes
Liquids
More dissolved than tablet
additional routes of admin
Topical
Gels absorbed quickly
The more liquid the base, the faster the absorption
Lotions absorpted more quickly than creams and creams absorbed more quickly than oint
Transdermal
patches
Inhaled
Rectal
Vaginal
Direct injection to a specific site—for example, heart, joints, nerves, central nervous system
3 factors distribution is determined by
BF to tissues
exiting the vasclar system
entering cells
distribution: BF to tissues
Drugs are carried by the blood to tissues and organs of the body
Blood flow determines the rate of delivery
Abscesses and tumors
Low regional blood flow affects therapy
Pus-filled pockets rather than internal blood vessels
Solid tumors have a limited blood supply
distribution: exiting the vasclar system
Typical capillary beds
Drugs pass between capillary cells rather than through them
lipid solable can pass thru cells
blood-brain barrier
Capillaries of the central nervous system have tight junctions that prevent free diffusion
Drugs must be able to pass through the cells of the capillary wall
Only drugs that are lipid soluble or that have a transport system can cross the blood-brain barrier to a significant degree
not fully developed at birth -more sensitive to CNS drugs, can delvelop quickly
placental drug transfer
Membranes of the placenta do NOT constitute an absolute barrier to the passage of drugs
Movement is determined in the same way as it is for other membranes
Risks with drug transfer
Birth defects: Mental retardation, gross malformations, low birth weight
Mother’s use of habitual opioids: Birth of drug-dependent baby
ionized, highly polar, protein bound drugs, and drugs that are substrates for the GP transporter excluded
distribution: protein binding
Drugs can form reversible bonds with various proteins
Plasma albumin is the most abundant and important protein -% of drg molecules bound depends on the strength of the attraction beteen albumin and drug
Large molecule that always remains in the bloodstream
Affects drug distribution
ex. warfarin and albumin have a strong attraction ~99% of drug is bond. Gentamicin has weak attracion to albmin, only ~ 10% is bound.
can cause drug interactions. drugs compete for binding sites on albmin. drugs become free form and increase intensity of bodys response to drug, can be toxic
distribution: entering cells
Some drugs must enter cells to reach the site of action
Most drugs must enter cells to undergo metabolism and excretion
Many drugs produce their effects by binding with receptors on the external surface of the cell membrane
These do not need to cross the cell membrane to act
hepatic drug-metablizing enzymes
Most drug metabolism that takes place in the liver is performed by the hepatic microsomal enzyme system, which is also known as the P450 system
Metabolism does not always result in a smaller molecule
therapuetic consequences of drug metabolism
Accelerated renal drug excretion
Drug inactivation
Increased therapeutic action
Ex. Codeine turns into morphine
Activation of prodrugs
Compound that is inactive when administrated, then is metabolized into active fom
Advantage if drug can’t cross BBB
Increased or decreased toxicity
Conversion of tylenol produces hepatotoxic metabolte
special considerations in drug metabolism
Age
Infants liver is not fully active until 1y
Old decrease in metabolism
Induction or inhibition of drug-metabolizing enzymes
Drugs that are p450 substrates
Inducers increased metabolism by stimulating enzyme synthesis -> decrease active drug
Inhibiters decrease metabolism -> increase in active drug
First-pass effect
rapid hepatic inactivation of certain oral drugs. when drugs are absorbed thru GI tract, they go to the liver via hepatic portal vein before systemic circ, drug could be inactivated on first pass thru liver -no therapuetic effect. give drug parentally to prevent this.
Nutritional status
Cofactors need to metabolism
Competition among drugs
Decreases rate at which one or both metablized
Drugs can accumulate -> toxic
enterohepatic recirculation
Repeating cycle in which drug is transported
From the liver into the duodenum (via the bile duct)
Back to the liver via the portal blood
Limited to drugs that have undergone glucuronidation (converts lipid soluable drugs to water soluable forms by binding to glucronic acid)
Glucuronide can be removed in duodenum, allowing for transport back across the intestinal wall into blood
allows drug to stay in body longer
Renal routes of drug excretion
Glomerular filtration
Small drugs are pushed out thru cap wall to tubular urine. Drugs bound to albumin are too big to pass thru urine, so stay in blood
Passive tubular reabsorption
[ ] of drug is lower in blood than tubule. This [ ] gradient is a driving force to move drugs from tubules back into blood
Lipid soluable drugs readily cross membrane -> passive reabsorption back into blood.
Nonlipid soluable remain in urine and excreted.
Active tubular secretion
Active transport system that pumps drugs from blood to urine
nonrenal route of drug excretion
Breast milk
Other nonrenal routes of excretion
Bile - drugs that do not undergo Enterohepatic recirculation excrete thru feces
Lungs (especially anesthesia)
Sweat/saliva (small amounts)
time course of drug responses
Plasma drug levels
Single-dose time course
Drug half-life
Drug levels produced with repeated doses
plasma drug levels: clinical sigificance
providers monitor PDL to regulate drug responses.
drug responses rt drug [ ] at site of action (near impossible)
direct corrlation between therapuetic and toxic responses and the amount of drug present in the plasma